Tag Archives: melanoma

Medical News Today: Modified herpes virus effective against late-stage melanoma

A new treatment with a genetically modified herpes virus is effective against stage 3B and stage 4 melanoma, a recent human study confirms. A genetically modified herpes virus is demonstrably effective against stage 3 melanoma, researchers show. In 2015, the United States Food and Drug Administration (FDA) approved the use of talimogene laherparepvec (TVEC) for… Read More »

NICE clears Pierre Fabre's targeted melanoma combo to take on Novartis, Roche drugs

Thanks to new guidance from England’s drug cost watchdog, Novartis and Roche will be getting some fresh targeted melanoma competition from French pharma lab Pierre Fabre.  In guidance published Friday, England’s National Institute for Health and Care Excellence signed off on Pierre Fabre’s combo of Braftovi and Mektovi to treat adult patients with unresectable or metastatic BRAF V600 mutation-positive melanoma.… Read More »

Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model

Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients. ACT is already available in the clinic for some diseases — CAR… Read More »